Infertile marginal zone lymphoma is a serious disease, but has a better prognosis than other aggressive lymphomas.
Infertile marginal zone lymphoma is a non-Hodgkin’s lymphoma that progresses at a slower rate than aggressive lymphomas (e.g., angioimmunoblastic T-cell lymphoma, etc.), and therefore patients with this disease have a longer survival period. However, it is a malignant disease of the blood system that is difficult to cure completely.
Although inert marginal zone lymphoma progresses slowly, the disease will continue to progress without treatment. There is variability in the disease from patient to patient and the rate of progression is not exactly the same. Therefore, inert marginal zone lymphoma is a more serious condition.
As the disease progresses there may be progressive enlargement of the spleen, enlargement of lymph nodes, peripheral blood cytopenia and other manifestations, which need to be actively treated according to the patient’s specific condition by formulating an individualized treatment plan, so as to put the disease into remission in order to prolong the survival period. Drugs include rituximab, vincristine, cyclophosphamide and so on.
It is recommended that patients with inert marginal zone lymphoma should consult the hematology department in a timely manner, complete relevant examinations to evaluate their conditions, and under the guidance of physicians, individualized treatment should be carried out.